Correction: Refractory Mycobacterium genavense infection secondary to thymoma-associated endogenous IL-12 inhibitor

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628655/
https://www.ncbi.nlm.nih.gov/pubmed/36339328
http://dx.doi.org/10.1136/bmjno-2022-000285corr1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628655/
https://www.ncbi.nlm.nih.gov/pubmed/36339328
http://dx.doi.org/10.1136/bmjno-2022-000285corr1

Ejemplares similares